Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer

Histology and Histopathology

Volumn 15, Issue 2, 2000, Pages 455-462

  Sanz Ortega, Julian ^a   Steinberg, S M ^b   Moro, E ^a   Saez, M ^a   Lopez, J A ^a   Sierra, E ^a   Sanz Esponera, J ^a   Merino, M J ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Angiogenesis; Gastric cancer; p53; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MYC PROTEIN; ONCOPROTEIN; PROTEIN P53;

ADULT; AGED; ANGIOGENESIS; ARTICLE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033996667     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Araya M., Terashima M. and Takagane E. (1997). Microvessel counts predicts metastasis and prognosis in patients with gastric cancer. J. Surg. Oncol. 65, 2326.
2. Bosari S., Lee A.K.C., Delellis R.A., Wiley B.D., Heatley G.J. and Silverman M.L. (1992). Microvessel quantitation and prognosis in invasive breast carcinoma. Human Pathol. 23, 755-761.
3. Brawer M.K., Deering P.E., Brown H., Preston S.D. and Bigler S.A. (1994). Predictors of pathologic stage in prostatic carcinomas. Cancer 73, 678-687.
4. Chen P.L., Chen X., Bookstein R. and Lee W.H. (1990). Genetic mechanism of tumor suppression by the human p53 gene. Science 250, 1576-1579.
5. Cox D. (1972). Regression models and lifetables. J. Royal Stat. Soc. 34, 187-202.
6. Fotsis T., Zhang Y.M., Pepper M.S., Adlercreutz H., Montesano R., Nawroth P.P. and Schweigener L. (1994). The endogenous estrogen metabolite 2-Methoxyoestradiol inhibits angiogenesis and suppresses tumor growth. Nature 368, 237-239.
7. Gabbert H.E., Mueller W., Schneider A. and Meer S. (1995). The relationship of p53 expression to the prognosis of 418 patients with gastric cancer. Cancer 76, 720.
8. Gasparini G., Weidner N., Maluta S., Pozza F., Boracchi P., Mezzatti M., Testolin A. and Bevilacqua P. (1993). Intratumoral MVD and p53 protein. Correlation with metastases in head and neck squamous cell carcinoma. Int. J. Cancer 55, 739-744.
9. Gasparini G., Bevilaqua P., Boracchi P., Maluta S., Pozza F. and Mezzati M. (1994a). Prognostic value of p53 expression in early stage breast cancer compared with tumor angiogenesis, EGF-r, c-ErbB2, Cathepsin D, DNA ploidy, parameter of cell kinetics and conventional features. Int. J. Oncol. 4, 155-162.
10. Gasparini G., Weidner N., Bevilaqua P., Maluta S., Della Palma P., Caffo O., Barbareslu P. and Pozza F. (1994b). Tumor microvessel density, p53 expression, tumor size and peritumoral vessel invasion are relevant prognostic markers in node negative breast cancer. J. Clin. Oncol. 12, 454-466.
11. Hollingsworth H.C., Steinberg S.M. and Kohn E. (1994). Tumor angiogenesis in advanced-stage ovarian cancer. Lab. Invest. 70, A89.
12. Horak E.R., Harris A.L., Stuart N. and Bicknell R. (1993). Angiogenesis in breast cancer. Ann. NY Acad. Sci. 698, 71-84.
13. Hulevy O., Michalowitz D. and Oren M. (1990). Different tumor derived p53 mutants exhibit distinct biological activities. Science 250, 113-116.
14. Igarashi M., Oher O.K. and Kulsta H. (1998). The prognostic significance of MVD and thimidine Phosphorylase expression in squamous cell cancer of esophagus. Cancer 82, 1225-1282.
15. Kaplan E. and Meier P. (1958). Non-parametric estimation of incomplete observations. J. Am. Stat. Assoc. 53, 457-481.
16. Kiu Y.S., Chu H.D., Kim D.Y., Kim S.K. and Park C.S. (1993). Expression of cellular oncogenes in human gastric cancer, c-myc, c-ErbB2 and c-Ha-ras. J. Surg. Oncol. 54, 167-170.
17. Liotta L., Kleinerman J. and Saidel G. (1974). Quantitative relationships of intravascular tumor cells, tumor vessels and pulmonary metastasis following tumor implantation. Cancer Res, 34, 997-1004.
18. Macchiarini P., Fontanini G., Hardin H.J., Squartini F. and Angelotti C.A. (1992). Relation of neovascularization to metastases of non-small-cell lung cancer. Lancet 340, 145-146.
19. Maeda K., Chung A., Takatsuda S., Onada N., Kato Y. and Nitta Anamoto Y. (1995). Tumor angiogenesis is a predictor of recurrence in gastric cancer. J. Clin. Oncol . 3, 477-481
20. Mantel N. (1996). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem. Rep. 50, 163-170.
21. Martin H.M., Filipe M.J., Morris R.W., Lane D.P and Silvestre F. (1992). p53 expression and prognosis in gastric cancer. Int. J. Cancer 50, 859-862.
22. Ming S.C. and Goldman H. (1992). Pathology of the gastrointestinal tract. WB Saunders Company.
23. Motojima K., Furui J., Kohara N., Ito T. and Kanamatsu T. (1994). Expression of p53 protein in GC is not independently prognostic. Surgery 116, 889-895.
24. Motojima K., Furui J., Kohara N., Izawa K., Kanamatsu T. and Shiku H. (1994). erbB-2 expresion in well differentiated adenocarcinomas of the stomach predicts shorter survival after curative resection. Surgery 115, 349-354.
25. Nagy J.A., Brown L.F. and Senger D.R. (1989). Pathogenesis of tumor stroma generation. A critical role for leaky blood vessels and fibrin deposition. Biochim. Biophys. Acta 948, 305-326.
26. Nguyen N.M., Lehr J.E. and Prenta K.J. (1993). Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo. Anticancer Res. 13, 2143-2147.
27. Ninomiya I., Yonemura Y., Matsumato H. and Sugiyama K. (1991). Expression of c-myc gene product in gastric cancer. Oncology 48, 149-153.
28. Rastinejad F., Polverini P.F. and Bouck N.P. (1989). Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56, 345-355.
29. Sanz-Ortega J., Lopez J.A. and Sanz-Esponera J. (1995). Analisis de la ploidia mediante citometria de flujo en el cancer gastrico. Patologia 28, 1-6.
30. Sasano H., Date F., Imatani A., Asaki S. and Nagura H. (1992). Double immunostaining for c-erbB2 and p53 in human stomach cancer cells. Human Pathol. 24, 584-589.
31. Starzynska T., Bromley M., Ghosh A. and Stern P.L (1992). Prognostic significance of p53 expression in gastric and colorectal carcinoma. Br. J. Cancer 66, 558-56
32. Toi M., Kashitani J. and Tominaga T. (1993). Tumor angiogenesis is an independant prognostic indicator in primary breast carcinomas. Int . J. Cancer 55, 371-374.
33. Tokunaga A., Onda M., Okuda T. and Teramoto T. (1995). Clinical significance of EGF, EGFr and c-ErbB2 in human gastric cancer. Cancer 75, 1418.
34. Vacca A., Ribatti D., Roncali L., Lospalluti M., Serio G., Carrel S. and Dammacco F. (1993). Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67 kilodalton laminin receptor. Cancer 72, 455-461.
35. Vartanian R.K. and Weidner N. (1994). Correlation of intratumoral endothelial cell proliferation with microvessel density and tumor cell proliferation in breast carcinoma. Lab. Invest. 70, A23.
36. Weidner N., Folkman J., Pozza F., Bevilaqua P., Allred E.N., Moore D.H., Meli S. and Gasparini G. (1992). Tumor angiogenesis. A new significant independent prognostic indicator in early stage breast carcinoma. J. Natl. Cancer Inst. 84, 1875-1887.
37. Weidner N. (1993). Tumor angiogenesis. Review of current applications in tumor prognostication. Sem. Diagn. Pathol. 10, 302-313.
38. Weidner N., Carrol P.R., Flax J., Blunenfeld W. and Folkman J. (1993). Tumor angiogenesis correlates with metastases in invasive prostate cancer. Am. J. Pathol. 143, 401-403.
39. Weidner N. and Gasparini G. (1994). Determination of EGFr provides additional prognostic information to measuring tumor angiogenesis in breast cancer patients. Breast Cancer Res. Treat. 29, 97-107.
40. Weidner N., Semple J.P., Welch W.R. and Folkman J. (1991). Tumor angiogenesis and metastases. Correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 1-8.
41. White W.L, Graham C.H., Rivers J.K. and Kerbel R. (1994). Angiogenesis as a prognostic variable in malignant melanoma. Lab. Invest. 70, A50.